Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer.

Krasimira Aleksandrova,Heiner Boeing,Ute Nöthlings,Mazda Jenab,Veronika Fedirko,Rudolf Kaaks,Annekatrin Lukanova,Antonia Trichopoulou,Dimitrios Trichopoulos,Paolo Boffetta,Elisabeth Trepo,Sabine Westhpal,Talita Duarte-Salles,Magdalena Stepien,Kim Overvad,Anne Tjønneland,Jytte Halkjær,Marie Christine Boutron-Ruault,Laure Dossus,Antoine Racine,Pagona Lagiou,Christina Bamia,Vassiliki Benetou,Claudia Agnoli,Domenico Palli,Salvatore Panico,Rosario Tumino,Paolo Vineis,Bas Bueno-de-Mesquita,Petra H. Peeters,Inger T. Gram,Eiliv Lund,Elisabete Vainio Weiderpass,J. Ramón Quirós,Antonio Agudo,María José Sánchez,Diana Gavrila,Aurelio Barricarte,Miren Dorronsoro,Bodil Ohlsson,Björn Lindkvist,Anders Johansson,Malin Sund,Kay-Tee Khaw,Nick Wareham,Ruth C. Travis,Elio Riboli,Tobias Pischon

Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer.

2014

Obesity and associated metabolic disorders have been implicated in liver carcinogenesis; however there is little data on the role of obesity-related biomarkers on liver cancer risk. We studied pros ...

Keywords:

Diabetes mellitus
Inflammation
Liver cancer
Gastroenterology
Case-control study
Biliary tract
Cancer
Biomarker (medicine)
Biliary tract neoplasm
Medicine
Internal medicine
Prospective cohort study
Obesity

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

133

Citations